Neuvivo (Venture)
Funding Details
- Awarder
- Inbox
- Date Award
- June 15, 2023
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $11,000,000
Company Info
- Company Description
- Neuvivo is a late clinical-stage biopharmaceutical company developing a new ALS treatment.
- Market
- Neurodegenerative diseases
- Location
- Palo Alto, California, USA
- Coinvestors
- PrimeStreet Capital